$7.27 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 64 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KLXI | KLX INC | $127,029,000 | -3.5% | 4,097,700 | 0.0% | 1.75% | +38.7% | |
| NQ MOBILE INCnote 4.000%10/1 | $68,999,000 | +2.8% | 79,479,000 | 0.0% | 0.95% | +47.7% | ||
| CI | CIGNA CORPORATIONput | $63,995,000 | -6.7% | 500,000 | 0.0% | 0.88% | +34.1% | |
| SYT | SYNGENTA AGsponsored adr | $14,634,000 | -7.3% | 190,571 | 0.0% | 0.20% | +33.1% | |
| NVET | NEXVET BIOPHARMA PUB LTD CO | $12,316,000 | +40.9% | 2,648,696 | 0.0% | 0.17% | +101.2% | |
| CLUBQ | TOWN SPORTS INTL HLDGS INC | $11,043,000 | -5.2% | 4,060,082 | 0.0% | 0.15% | +36.9% | |
| VIP | VIMPELCOM LTDsponsored adr | $6,496,000 | -8.9% | 1,674,147 | 0.0% | 0.09% | +30.9% | |
| ZFGN | ZAFGEN INC | $5,024,000 | -10.3% | 838,800 | 0.0% | 0.07% | +27.8% | |
| EJ | E HOUSE CHINA HLDGS LTDadr | $2,453,000 | +4.0% | 379,202 | 0.0% | 0.03% | +47.8% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.